Studies reported that overexpression of Oct4 and Sox2 were associated with drug-resistance, including chemotherapy, radiation therapy and target therapy in lung cancer and bladder cancer, malignant mesothelioma cells and osteosarcoma [39–42]. The gene discussed is POU5F1; the disease is urinary bladder carcinoma.